Timon E. Adolph

13.0k total citations · 10 hit papers
68 papers, 5.5k citations indexed

About

Timon E. Adolph is a scholar working on Molecular Biology, Epidemiology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Timon E. Adolph has authored 68 papers receiving a total of 5.5k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 33 papers in Epidemiology and 12 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Timon E. Adolph's work include Liver Disease Diagnosis and Treatment (24 papers), Gut microbiota and health (23 papers) and Diet, Metabolism, and Disease (11 papers). Timon E. Adolph is often cited by papers focused on Liver Disease Diagnosis and Treatment (24 papers), Gut microbiota and health (23 papers) and Diet, Metabolism, and Disease (11 papers). Timon E. Adolph collaborates with scholars based in Austria, Germany and United States. Timon E. Adolph's co-authors include Herbert Tilg, Alexander R. Moschen, Romana R. Gerner, Eran Elinav, Niv Zmora, Michael Trauner, Felix Grabherr, Christoph Grander, Arthur Kaser and Verena Wieser and has published in prestigious journals such as New England Journal of Medicine, Nature Medicine and Nature Communications.

In The Last Decade

Timon E. Adolph

67 papers receiving 5.4k citations

Hit Papers

The intestinal microbiota... 2018 2026 2020 2023 2019 2018 2022 2021 2021 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The intestinal microbiota fuelling metabolic inflammation
    2019 738 citations Herbert Tilg, Timon E. Adolph et al. profile →
  2. The Intestinal Microbiota in Colorectal Cancer
    2018 552 citations Herbert Tilg, Timon E. Adolph et al. profile →
  3. Gut-liver axis: Pathophysiological concepts and clinical implications
    2022 426 citations Herbert Tilg, Timon E. Adolph et al. profile →
  4. Non-alcoholic fatty liver disease: the interplay between metabolism, microbes and immunity
    2021 315 citations Herbert Tilg, Timon E. Adolph et al. Nature Metabolism profile →
  5. Calprotectin: from biomarker to biological function
    2021 274 citations Almina Jukic, Herbert Tilg et al. Gut profile →
  6. Multiple Parallel Hits Hypothesis in Nonalcoholic Fatty Liver Disease: Revisited After a Decade
    2020 269 citations Herbert Tilg, Timon E. Adolph et al. Hepatology profile →
  7. The metabolic nature of inflammatory bowel diseases
    2022 184 citations Timon E. Adolph, Moritz Meyer et al. Nature Reviews Gastroenterology & Hepatology profile →
  8. Postacute COVID-19 is Characterized by Gut Viral Antigen Persistence in Inflammatory Bowel Diseases
    2022 173 citations Andreas Zollner, Robert Koch et al. Gastroenterology profile →
  9. Western diets and chronic diseases
    2024 57 citations Timon E. Adolph, Herbert Tilg Nature Medicine profile →
  10. Adipokines: masterminds of metabolic inflammation
    2024 54 citations Herbert Tilg, Gianluca Ianiro et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Timon E. Adolph 2.6k 2.0k 1.0k 730 730 68 5.5k
Laurent Dubuquoy 2.6k 1.0× 1.3k 0.7× 753 0.7× 1.1k 1.6× 1.1k 1.5× 104 6.1k
Cristóbal Richart 1.4k 0.5× 2.6k 1.3× 1.5k 1.5× 721 1.0× 746 1.0× 216 6.5k
Lixin Zhu 3.3k 1.3× 2.5k 1.2× 1.5k 1.4× 755 1.0× 240 0.3× 129 6.0k
Chengcheng Jin 3.7k 1.4× 1.6k 0.8× 908 0.9× 758 1.0× 1.8k 2.4× 38 6.8k
Judy K. Shigenaga 2.0k 0.8× 1.3k 0.7× 748 0.7× 1.5k 2.0× 1.1k 1.5× 65 5.8k
Oren Shibolet 1.1k 0.4× 2.5k 1.3× 758 0.7× 868 1.2× 865 1.2× 153 5.6k
Matteo Sérino 3.4k 1.3× 940 0.5× 2.0k 1.9× 650 0.9× 490 0.7× 55 5.5k
Susan S. Baker 2.5k 1.0× 2.6k 1.3× 1.4k 1.4× 843 1.2× 187 0.3× 121 6.6k
Valentina Petito 2.3k 0.9× 920 0.5× 942 0.9× 518 0.7× 370 0.5× 85 4.2k
Da-Zhong Xu 2.3k 0.9× 1.3k 0.7× 975 1.0× 1.2k 1.6× 1.3k 1.8× 180 7.4k

Countries citing papers authored by Timon E. Adolph

Since Specialization
Citations

This map shows the geographic impact of Timon E. Adolph's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timon E. Adolph with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timon E. Adolph more than expected).

Fields of papers citing papers by Timon E. Adolph

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Timon E. Adolph. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timon E. Adolph. The network helps show where Timon E. Adolph may publish in the future.

Co-authorship network of co-authors of Timon E. Adolph

This figure shows the co-authorship network connecting the top 25 collaborators of Timon E. Adolph. A scholar is included among the top collaborators of Timon E. Adolph based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Timon E. Adolph. Timon E. Adolph is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fusco, William G., Timon E. Adolph, Giovanni Cammarota, et al.. (2025). Gut microbiota and atherosclerosis. Gut. gutjnl–2025. 2 indexed citations
2.
Zollner, Andreas, Robert Koch, Almina Jukic, et al.. (2024). Clearance of Gut Mucosal SARS-CoV-2 Antigens and Postacute COVID-19 After 2 Years in Patients With Inflammatory Bowel Disease. Gastroenterology. 167(3). 604–607.e8. 3 indexed citations
3.
Schwärzler, Julian, Lisa Mayr, Felix Grabherr, Herbert Tilg, & Timon E. Adolph. (2024). Epithelial metabolism as a rheostat for intestinal inflammation and malignancy. Trends in Cell Biology. 34(11). 913–927. 3 indexed citations
4.
Adolph, Timon E. & Herbert Tilg. (2024). Western diets and chronic diseases. Nature Medicine. 30(8). 2133–2147. 57 indexed citations breakdown →
5.
Adolph, Timon E., Moritz Meyer, Almina Jukic, & Herbert Tilg. (2024). Heavy arch: from inflammatory bowel diseases to metabolic disorders. Gut. 73(8). 1376–1387. 31 indexed citations
6.
Tilg, Herbert, Timon E. Adolph, & Frank Tacke. (2023). Therapeutic modulation of the liver immune microenvironment. Hepatology. 78(5). 1581–1601. 18 indexed citations
7.
Chen, Hung‐Chang, Valentina Carbonaro, Kamal Kishore, et al.. (2022). Cell-autonomous Hedgehog signaling controls Th17 polarization and pathogenicity. Nature Communications. 13(1). 4075–4075. 17 indexed citations
8.
Adolph, Timon E. & Jingwan Zhang. (2022). Diet fuelling inflammatory bowel diseases: preclinical and clinical concepts. Gut. 71(12). 2574–2586. 80 indexed citations
9.
Jaschke, Nikolai, Anupam Sinha, Timon E. Adolph, et al.. (2022). Dickkopf1 fuels inflammatory cytokine responses. Communications Biology. 5(1). 1391–1391. 10 indexed citations
10.
Adolph, Timon E., Moritz Meyer, Julian Schwärzler, et al.. (2022). The metabolic nature of inflammatory bowel diseases. Nature Reviews Gastroenterology & Hepatology. 19(12). 753–767. 184 indexed citations breakdown →
11.
Zollner, Andreas, Robert Koch, Almina Jukic, et al.. (2022). Postacute COVID-19 is Characterized by Gut Viral Antigen Persistence in Inflammatory Bowel Diseases. Gastroenterology. 163(2). 495–506.e8. 173 indexed citations breakdown →
12.
Schwärzler, Julian, Lisa Mayr, Felix Grabherr, et al.. (2022). Adipocyte GPX4 protects against inflammation, hepatic insulin resistance and metabolic dysregulation. International Journal of Obesity. 46(5). 951–959. 23 indexed citations
13.
Effenberger, Maria, Andreas Kronbichler, Felix Grabherr, et al.. (2021). Using Infodemiology Metrics to Assess Public Interest in Liver Transplantation: Google Trends Analysis. Journal of Medical Internet Research. 23(8). e21656–e21656. 3 indexed citations
14.
Tilg, Herbert, Timon E. Adolph, Michael Dudek, & Percy A. Knolle. (2021). Non-alcoholic fatty liver disease: the interplay between metabolism, microbes and immunity. Nature Metabolism. 3(12). 1596–1607. 315 indexed citations breakdown →
15.
Tilg, Herbert, Timon E. Adolph, & Alexander R. Moschen. (2020). Multiple Parallel Hits Hypothesis in Nonalcoholic Fatty Liver Disease: Revisited After a Decade. Hepatology. 73(2). 833–842. 269 indexed citations breakdown →
16.
Sangineto, Moris, Felix Grabherr, Timon E. Adolph, et al.. (2020). Dimethyl fumarate ameliorates hepatic inflammation in alcohol related liver disease. Liver International. 40(7). 1610–1619. 27 indexed citations
17.
Adolph, Timon E., Felix Grabherr, Lisa Mayr, et al.. (2018). Weight Loss Induced by Bariatric Surgery Restricts Hepatic GDF15 Expression. Journal of Obesity. 2018. 1–6. 15 indexed citations
18.
Adolph, Timon E., Lisa Mayr, Felix Grabherr, & Herbert Tilg. (2018). Paneth Cells and their Antimicrobials in Intestinal Immunity. Current Pharmaceutical Design. 24(10). 1121–1129. 23 indexed citations
19.
Wieser, Verena, Timon E. Adolph, Christoph Grander, et al.. (2016). Adipose type I interferon signalling protects against metabolic dysfunction. Gut. 67(1). 157–165. 61 indexed citations
20.
Tschurtschenthaler, Markus, Jun Wang, Cornelia Fricke, et al.. (2014). Type I interferon signalling in the intestinal epithelium affects Paneth cells, microbial ecology and epithelial regeneration. Gut. 63(12). 1921–1931. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Laurent Dubuquoy Breakdown of academic impact, for papers by Cristóbal Richart Breakdown of academic impact, for papers by Lixin Zhu Breakdown of academic impact, for papers by Chengcheng Jin Breakdown of academic impact, for papers by Judy K. Shigenaga Breakdown of academic impact, for papers by Oren Shibolet Breakdown of academic impact, for papers by Matteo Sérino Breakdown of academic impact, for papers by Susan S. Baker Breakdown of academic impact, for papers by Valentina Petito Breakdown of academic impact, for papers by Da-Zhong Xu
Rankless by CCL
2026